MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases

World Journal of Gastroenterology

Volumn 19, Issue 44, 2013, Pages 7947-7954

  De Iudicibus, Sara ^a   Lucafò, Marianna ^b   Martelossi, Stefano ^a   Pierobon, Chiara ^a   Ventura, Alessandro ^b   Decorti, Giuliana ^b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Glucocorticoids; Inflammatory bowel diseases; MicroRNA; Molecular markers; Pharmacogenomics

Indexed keywords

BUDESONIDE; DEXAMETHASONE; FAS ANTIGEN; FAS LIGAND; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; METHYLPREDNISOLONE; MICRORNA; MICRORNA 124A; MICRORNA 15; MICRORNA 15B; MICRORNA 16; MICRORNA 17; MICRORNA 17-92; MICRORNA 18; MICRORNA 355; MICRORNA 98; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ASTHMA; CROHN DISEASE; DRUG DOSE REDUCTION; DRUG RESPONSE; GENE CONTROL; GENE EXPRESSION; HUMAN; INFLAMMATORY BOWEL DISEASE; REVIEW; ULCERATIVE COLITIS;

GLUCOCORTICOIDS; INFLAMMATORY BOWEL DISEASES; MICRORNA; MOLECULAR MARKERS; PHARMACOGENOMICS;

ANIMALS; BIOLOGICAL MARKERS; GENE EXPRESSION REGULATION; GENETIC TESTING; GLUCOCORTICOIDS; HUMANS; INDIVIDUALIZED MEDICINE; INFLAMMATORY BOWEL DISEASES; MICRORNAS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 84888617067     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i44.7947     Document Type: Review

References (101)

1. Friedman S. General principles of medical therapy of inflam matory bowel disease. Gastroenterol Clin North Am 2004; 33: 191-208, [PMID: 15177534 DOI: 10.1016/j.gtc.2004.02.003]
2. De Iudicibus S, Franca R, Martelossi S, Ventura A, Decorti G. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. World J Gastroenterol 2011; 17: 1095-1108 [PMID: 21448414 DOI: 10.3748/wjg.v17.i9.1095]
3. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 2009; 373: 1905-1917 [PMID: 19482216 DOI: 10.1016/S0140-6736(09)60326-3]
4. Barnes PJ. Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol 2010; 120: 76-85 [PMID: 20188830 DOI: 10.1016/j.jsbmb.2010.02.018]
5. Farrell RJ, Kelleher D. Glucocorticoid resistance in inflammatory bowel disease. J Endocrinol 2003; 178: 339-346 [PMID: 12967327]
6. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010; 466: 835-840 [PMID: 20703300 DOI: 10.1038/nature09267]
7. Rigoutsos I. New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites. Cancer Res 2009; 69: 3245-3248 [PMID: 19351814 DOI:10.1158/0008-5472.CAN-09-0352]
8. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297 [PMID: 14744438]
9. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011; 39: D152-D157 [PMID: 21037258 DOI: 10.1093/nar/ gkq1027]
10. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006; 34: D140-D144 [PMID: 16381832 DOI: 10.1093/nar/gkj112]
11. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003; 115: 787-798 [PMID: 14697198]
12. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20 [PMID: 15652477 DOI: 10.1016/j.cell.2004.12.035]
13. Friedman Y, Balaga O, Linial M. Working together: combinatorial regulation by microRNAs. Adv Exp Med Biol 2013; 774: 317-337 [PMID: 23377980 DOI: 10.1007/978-94-007-5590-1_16]
14. Singh TR, Gupta A, Suravajhala P. Challenges in the miRNA research. Int J Bioinform Res Appl 2013; 9: 576-583 [PMID: 24084238 DOI: 10.1504/IJBRA.2013.056620]
15. Leaman D, Chen PY, Fak J, Yalcin A, Pearce M, Unnerstall U, Marks DS, Sander C, Tuschl T, Gaul U. Antisense-mediated depletion reveals essential and specific functions of microRNAs in Drosophila development. Cell 2005; 121: 1097-1108 [PMID: 15989958 DOI: 10.1016/j.cell.2005.04.016]
16. Li X, Wang J, Jia Z, Cui Q, Zhang C, Wang W, Chen P, Ma K, Zhou C. MiR-499 Regulates Cell Proliferation and Apoptosis during Late-Stage Cardiac Differentiation via Sox6 and Cyclin D1. PLoS One 2013; 8: e74504 [PMID: 24040263 DOI: 10.1371/journal.pone.0074504]
17. Palumbo S, Miracco C, Pirtoli L, Comincini S. Emerging Roles of microRNA in Modulating Cell-Death Processes in Malignant Glioma. J Cell Physiol 2014; 229: 277-286 [PMID: 23929496 DOI: 10.1002/jcp.24446]
18. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83-86 [PMID: 14657504 DOI: 10.1126/science.1091903]
19. Khoshgoo N, Kholdebarin R, Iwasiow BM, Keijzer R. MicroRNAs and lung development. Pediatr Pulmonol 2013; 48: 317-323 [PMID: 23281163 DOI: 10.1002/ppul.22739]
20. Mathieu J, Ruohola-Baker H. Regulation of stem cell populations by microRNAs. Adv Exp Med Biol 2013; 786: 329-351 [PMID: 23696365 DOI: 10.1007/978-94-007-6621-1_18]
21. Giraldez AJ, Cinalli RM, Glasner ME, Enright AJ, Thomson JM, Baskerville S, Hammond SM, Bartel DP, Schier AF. MicroRNAs regulate brain morphogenesis in zebrafish. Science 2005; 308: 833-838 [PMID: 15774722 DOI: 10.1126/science.1109020]
22. Marrone AK, Ho J. MicroRNAs: potential regulators of renal development genes that contribute to CAKUT. Pediatr Nephrol 2013; Epub ahead of print [PMID: 23996519 DOI: 10.1007/s00467-013-2599-0]
23. Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2012; 4: 143-159 [PMID: 22351564 DOI: 10.1002/emmm.201100209]
24. Di Leva G, Garofalo M, Croce CM. MicroRNAs in Cancer. Annu Rev Pathol 2013; Epub ahead of print [PMID: 24079833 DOI: 10.1146/annurev-pathol-012513-104715]
25. Li T, Leong MH, Harms B, Kennedy G, Chen L. MicroRNA-21 as a potential colon and rectal cancer biomarker. World J Gastroenterol 2013; 19: 5615-5621 [PMID: 24039353 DOI: 10.3748/wjg.v19.i34.5615]
26. Rothschild SI. Epigenetic Therapy in Lung Cancer-Role of microRNAs. Front Oncol 2013; 3: 158 [PMID: 23802096 DOI: 10.3389/fonc.2013.00158]
27. Lu LF, Liston A. MicroRNA in the immune system, microRNA as an immune system. Immunology 2009; 127: 291-298 [PMID: 19538248 DOI: 10.1111/j.1365-2567.2009.03092.x]
28. Raisch J, Darfeuille-Michaud A, Nguyen HT. Role of microRNAs in the immune system, inflammation and cancer. World J Gastroenterol 2013; 19: 2985-2996 [PMID: 23716978 DOI:10.3748/wjg.v19.i20.2985]
29. Bronevetsky Y, Ansel KM. Regulation of miRNA biogenesis and turnover in the immune system. Immunol Rev 2013; 253: 304-316 [PMID: 23550654 DOI: 10.1111/imr.12059]
30. Papaconstantinou I, Stamatis K, Tzathas C, Vassiliou I, Giokas G, Gazouli M. The role of variations within microRNA in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2013; 25: 399-403 [PMID: 23466513 DOI: 10.1097/ MEG.0b013e32835c34ea]
31. Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, Bayless TM, Brant SR, Chakravarti S, Kwon JH. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008; 135: 1624-1635 [PMID: 18835392 DOI: 10.1053/j.gastro.2008.07.068]
32. Archanioti P, Gazouli M, Theodoropoulos G, Vaiopoulou A, Nikiteas N. Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease. J Crohns Colitis 2011; 5: 520-524 [PMID: 22115369 DOI: 10.1016/ j.crohns.2011.05.007]
33. Iborra M, Bernuzzi F, Invernizzi P, Danese S. MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response. Autoimmun Rev 2012; 11: 305-314 [PMID: 20627134 DOI: 10.1016/j.autrev.2010.07.002]
34. Rukov JL, Shomron N. MicroRNA pharmacogenomics: post-transcriptional regulation of drug response. Trends Mol Med 2011; 17: 412-423 [PMID: 21652264 DOI: 10.1016/ j.molmed.2011.04.003]
35. Munkholm P, Langholz E, Davidsen M, Binder V. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 1994; 35: 360-362 [PMID: 8150347]
36. Faubion WA, Loftus EV, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001; 121: 255-260 [PMID: 11487534]
37. Hyams J, Markowitz J, Lerer T, Griffiths A, Mack D, Bousvaros A, Otley A, Evans J, Pfefferkorn M, Rosh J, Rothbaum R, Kugathasan S, Mezoff A, Wyllie R, Tolia V, delRosario JF, Moyer MS, Oliva-Hemker M, Leleiko N. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol 2006; 4: 1118-1123 [PMID: 16820327 DOI:10.1016/j.cgh.2006.04.008]
38. Ho GT, Chiam P, Drummond H, Loane J, Arnott ID, Satsangi J. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther 2006; 24: 319-330 [PMID: 16842459 DOI: 10.1111/j.1365-2036.2006.02974.x]
39. Hyams JS, Lerer T, Griffiths A, Pfefferkorn M, Kugathasan S, Evans J, Otley A, Carvalho R, Mack D, Bousvaros A, Rosh J, Mamula P, Kay M, Crandall W, Oliva-Hemker M, Keljo D, LeLeiko N, Markowitz J. Long-term outcome of maintenance infliximab therapy in children with Crohn's disease. Inflamm Bowel Dis 2009; 15: 816-822 [PMID: 19107783 DOI: 10.1002/ ibd.20845]
40. Beato M, Herrlich P, Schütz G. Steroid hormone receptors: many actors in search of a plot. Cell 1995; 83: 851-857 [PMID: 8521509]
41. Davies P, Rushmere NK. The structure and function of steroid receptors. Sci Prog 1988; 72: 563-578 [PMID: 3068798]
42. Theriault A, Boyd E, Harrap SB, Hollenberg SM, Connor JM. Regional chromosomal assignment of the human glucocorticoid receptor gene to 5q31. Hum Genet 1989; 83: 289-291 [PMID: 2793174]
43. Baker AC, Green TL, Chew VW, Tung K, Amini A, Lim D, Cho K, Greenhalgh DG. Enhanced steroid response of a human glucocorticoid receptor splice variant. Shock 2012; 38: 11-17 [PMID: 22706020 DOI: 10.1097/SHK.0b013e318257c0c0]
44. Lu NZ, Cidlowski JA. The origin and functions of multiple human glucocorticoid receptor isoforms. Ann N Y Acad Sci 2004; 1024: 102-123 [PMID: 15265776 DOI: 10.1196/annals.1321.008]
45. Revollo JR, Cidlowski JA. Mechanisms generating diversity in glucocorticoid receptor signaling. Ann N Y Acad Sci 2009; 1179: 167-178 [PMID: 19906239 DOI: 10.1111/ j.1749-6632.2009.04986.x]
46. Zhou J, Cidlowski JA. The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 2005; 70: 407-417 [PMID: 15862824 DOI: 10.1016/ j.steroids.2005.02.006]
47. Oakley RH, Sar M, Cidlowski JA. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J Biol Chem 1996; 271: 9550-9559 [PMID: 8621628]
48. Wu I, Shin SC, Cao Y, Bender IK, Jafari N, Feng G, Lin S, Cidlowski JA, Schleimer RP, Lu NZ. Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes. Cell Death Dis 2013; 4: e453 [PMID: 23303127 DOI: 10.1038/cddis.2012.193]
49. Lu NZ, Cidlowski JA. Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell 2005; 18: 331-342 [PMID: 15866175 DOI: 10.1016/j.molcel.2005.03.025]
50. Hutchison KA, Scherrer LC, Czar MJ, Ning Y, Sanchez ER, Leach KL, Deibel MR, Pratt WB. FK506 binding to the 56-kilodalton immunophilin (Hsp56) in the glucocorticoid receptor heterocomplex has no effect on receptor folding or function. Biochemistry 1993; 32: 3953-3957 [PMID: 7682438]
51. Pratt WB, Morishima Y, Murphy M, Harrell M. Chaperoning of glucocorticoid receptors. Handb Exp Pharmacol 2006; (172): 111-138 [PMID: 16610357]
52. Gross KL, Lu NZ, Cidlowski JA. Molecular mechanisms regulating glucocorticoid sensitivity and resistance. Mol Cell Endocrinol 2009; 300: 7-16 [PMID: 19000736 DOI: 10.1016/ j.mce.2008.10.001]
53. Wikström AC. Glucocorticoid action and novel mechanisms of steroid resistance: role of glucocorticoid receptor-interacting proteins for glucocorticoid responsiveness. J Endocrinol 2003; 178: 331-337 [PMID: 12967326]
54. Qian X, Zhu Y, Xu W, Lin Y. Glucocorticoid receptor and heat shock protein 90 in peripheral blood mononuclear cells from asthmatics. Chin Med J (Engl) 2001; 114: 1051-1054 [PMID: 11677765]
55. Raddatz D, Middel P, Bockemühl M, Benöhr P, Wissmann C, Schwörer H, Ramadori G. Glucocorticoid receptor expression in inflammatory bowel disease: evidence for a mucosal down-regulation in steroid-unresponsive ulcerative colitis. Aliment Pharmacol Ther 2004; 19: 47-61 [PMID: 14687166]
56. Matysiak M, Makosa B, Walczak A, Selmaj K. Patients with multiple sclerosis resisted to glucocorticoid therapy: abnormal expression of heat-shock protein 90 in glucocorticoid receptor complex. Mult Scler 2008; 14: 919-926 [PMID: 18573821 DOI: 10.1177/1352458508090666]
57. Charmandari E, Kino T. Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes. Eur J Clin Invest 2010; 40: 932-942 [PMID: 20649902 DOI: 10.1111/ j.1365-2362.2010.02336.x]
58. Damjanovic SS, Antic JA, Ilic BB, Cokic BB, Ivovic M, Ognjanovic SI, Isailovic TV, Popovic BM, Bozic IB, Tatic S, Matic G, Todorovic VN, Paunovic I. Glucocorticoid receptor and molecular chaperones in the pathogenesis of adrenal incidentalomas: potential role of reduced sensitivity to glucocorticoids. Mol Med 2012; 18: 1456-1465 [PMID: 23196783 DOI:10.2119/molmed.2012.00261]
59. Ouyang J, Chen P, Jiang T, Chen Y, Li J. Nuclear HSP90 regulates the glucocorticoid responsiveness of PBMCs in patients with idiopathic nephrotic syndrome. Int Immunopharmacol 2012; 14: 334-340 [PMID: 22926076 DOI: 10.1016/ j.intimp.2012.08.012]
60. Pemberton LF, Paschal BM. Mechanisms of receptor-mediated nuclear import and nuclear export. Traffic 2005; 6: 187-198 [PMID: 15702987 DOI: 10.1111/j.1600-0854.2005.00270.x]
61. Almawi WY, Melemedjian OK. Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor. J Leukoc Biol 2002; 71: 9-15 [PMID: 11781376]
62. Meijsing SH, Pufall MA, So AY, Bates DL, Chen L, Yamamoto KR. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 2009; 324: 407-410 [PMID: 19372434 DOI: 10.1126/science.1164265]
63. Nordeen SK, Suh BJ, Kühnel B, Hutchison CA. Structural determinants of a glucocorticoid receptor recognition element. Mol Endocrinol 1990; 4: 1866-1873 [PMID: 1964489]
64. De Bosscher K, Vanden Berghe W, Vermeulen L, Plaisance S, Boone E, Haegeman G. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Natl Acad Sci USA 2000; 97: 3919-3924 [PMID: 10760263]
65. Schäcke H, Döcke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002; 96: 23-43 [PMID: 12441176]
66. Schäcke H, Schottelius A, Döcke WD, Strehlke P, Jaroch S, Schmees N, Rehwinkel H, Hennekes H, Asadullah K. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc Natl Acad Sci USA 2004; 101: 227-232 [PMID: 14694204 DOI: 10.1073/pnas.0300372101]
67. Song IH, Gold R, Straub RH, Burmester GR, Buttgereit F. New glucocorticoids on the horizon: repress, don't activate! J Rheumatol 2005; 32: 1199-1207 [PMID: 16041872]
68. Chen R, Burke TF, Cumberland JE, Brummet M, Beck LA, Casolaro V, Georas SN. Glucocorticoids inhibit calciumand calcineurin-dependent activation of the human IL-4 promoter. J Immunol 2000; 164: 825-832 [PMID: 10623828]
69. Ing NH. Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger RNAs. Biol Reprod 2005; 72: 1290-1296 [PMID: 15728791 DOI:10.1095/biolreprod.105.040014]
70. Croxtall JD, van Hal PT, Choudhury Q, Gilroy DW, Flower RJ. Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells. Br J Pharmacol 2002; 135: 511-519 [PMID: 11815387 DOI: 10.1038/ sj.bjp.0704474]
71. Croxtall JD, Flower RJ. Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. Proc Natl Acad Sci USA 1992; 89: 3571-3575 [PMID: 1533045]
72. McConkey DJ, Nicotera P, Hartzell P, Bellomo G, Wyllie AH, Orrenius S. Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration. Arch Biochem Biophys 1989; 269: 365-370 [PMID: 2537063 DOI: 10.1016/0003-9861(89)90119-7]
73. Cohen JJ, Duke RC. Glucocorticoid activation of a calciumdependent endonuclease in thymocyte nuclei leads to cell death. J Immunol 1984; 132: 38-42 [PMID: 6317746]
74. Sionov RV. MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies. ISRN Hematol 2013; 2013: 348212 [PMID: 23431463 DOI: 10.1155/2013/348212]
75. Rainer J, Ploner C, Jesacher S, Ploner A, Eduardoff M, Mansha M, Wasim M, Panzer-Grümayer R, Trajanoski Z, Niederegger H, Kofler R. Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia. Leukemia 2009; 23: 746-752 [PMID: 19148136 DOI: 10.1038/leu.2008.370]
76. Molitoris JK, McColl KS, Distelhorst CW. Glucocorticoidmediated repression of the oncogenic microRNA cluster miR-17~92 contributes to the induction of Bim and initiation of apoptosis. Mol Endocrinol 2011; 25: 409-420 [PMID: 21239610 DOI: 10.1210/me.2010-0402]
77. Harada M, Pokrovskaja-Tamm K, Söderhäll S, Heyman M, Grander D, Corcoran M. Involvement of miR17 pathway in glucocorticoid-induced cell death in pediatric acute lymphoblastic leukemia. Leuk Lymphoma 2012; 53: 2041-2050 [PMID: 22475310 DOI: 10.3109/10428194.2012.678004]
78. Yan J, Jiang N, Huang G, Tay JL, Lin B, Bi C, Koh GS, Li Z, Tan J, Chung TH, Lu Y, Ariffin H, Kham SK, Yeoh AE, Chng WJ. Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia. Br J Haematol 2013; 163: 93-103 [PMID: 23888996 DOI: 10.1111/bjh.12489]
79. Smith LK, Shah RR, Cidlowski JA. Glucocorticoids modulate microRNA expression and processing during lymphocyte apoptosis. J Biol Chem 2010; 285: 36698-36708 [PMID: 20847043 DOI: 10.1074/jbc.M110.162123]
80. Ledderose C, Möhnle P, Limbeck E, Schütz S, Weis F, Rink J, Briegel J, Kreth S. Corticosteroid resistance in sepsis is influenced by microRNA-124--induced downregulation of glucocorticoid receptor-α. Crit Care Med 2012; 40: 2745-2753 [PMID: 22846781 DOI: 10.1097/CCM.0b013e31825b8ebc]
81. Liu L, Walker EA, Kissane S, Khan I, Murray PI, Rauz S, Wallace GR. Gene expression and miR profiles of human corneal fibroblasts in response to dexamethasone. Invest Ophthalmol Vis Sci 2011; 52: 7282-7288 [PMID: 21666241 DOI: 10.1167/ iovs.11-7463]
82. Lu S, Mukkada VA, Mangray S, Cleveland K, Shillingford N, Schorl C, Brodsky AS, Resnick MB. MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targets. PLoS One 2012; 7: e40676 [PMID: 22815788 DOI: 10.1371/journal.pone.0040676]
83. Williams AE, Larner-Svensson H, Perry MM, Campbell GA, Herrick SE, Adcock IM, Erjefalt JS, Chung KF, Lindsay MA. MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy. PLoS One 2009; 4: e5889 [PMID: 19521514 DOI: 10.1371/journal.pone.0005889]
84. Davis TE, Kis-Toth K, Szanto A, Tsokos GC. Glucocorticoids suppress T cell function by up-regulating microRNA-98. Arthritis Rheum 2013; 65: 1882-1890 [PMID: 23575983 DOI:10.1002/art.37966]
85. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. The role of site accessibility in microRNA target recognition. Nat Genet 2007; 39: 1278-1284 [PMID: 17893677 DOI: 10.1038/ng2135]
86. Vreugdenhil E, Verissimo CS, Mariman R, Kamphorst JT, Barbosa JS, Zweers T, Champagne DL, Schouten T, Meijer OC, de Kloet ER, Fitzsimons CP. MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain. Endocrinology 2009; 150: 2220-2228 [PMID: 19131573 DOI: 10.1210/ en.2008-1335]
87. Tessel MA, Benham AL, Krett NL, Rosen ST, Gunaratne PH. Role for microRNAs in regulating glucocorticoid response and resistance in multiple myeloma. Horm Cancer 2011; 2: 182-189 [PMID: 21761344 DOI: 10.1007/s12672-011-0072-8]
88. Biton M, Levin A, Slyper M, Alkalay I, Horwitz E, Mor H, Kredo-Russo S, Avnit-Sagi T, Cojocaru G, Zreik F, Bentwich Z, Poy MN, Artis D, Walker MD, Hornstein E, Pikarsky E, Ben-Neriah Y. Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk. Nat Immunol 2011; 12: 239-246 [PMID: 21278735 DOI: 10.1038/ni.1994]
89. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CM. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007; 179: 5082-5089 [PMID: 17911593]
90. Coskun M, Bjerrum JT, Seidelin JB, Nielsen OH. MicroRNAs in inflammatory bowel disease--pathogenesis, diagnostics and therapeutics. World J Gastroenterol 2012; 18: 4629-4634 [PMID: 23002331 DOI: 10.3748/wjg.v18.i34.4629]
91. Dalal SR, Kwon JH. The Role of MicroRNA in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y) 2010; 6: 714-722 [PMID: 21437020]
92. Wu F, Zhang S, Dassopoulos T, Harris ML, Bayless TM, Meltzer SJ, Brant SR, Kwon JH. Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis 2010; 16: 1729-1738 [PMID: 20848482 DOI: 10.1002/ ibd.21267]
93. Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L, Zeng Y, Miao R, Jin G, Ma H, Chen Y, Shen H. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 2008; 118: 2600-2608 [PMID: 18521189 DOI: 10.1172/JCI34934]
94. Hu Z. Insight into microRNA regulation by analyzing the characteristics of their targets in humans. BMC Genomics 2009; 10: 594 [PMID: 20003303 DOI: 10.1186/1471-2164-10-594]
95. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 2008; 105: 7269-7274 [PMID: 18474871 DOI: 10.1073/pnas.0802682105]
96. Tian T, Shu Y, Chen J, Hu Z, Xu L, Jin G, Liang J, Liu P, Zhou X, Miao R, Ma H, Chen Y, Shen H. A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev 2009; 18: 1183-1187 [PMID: 19293314 DOI: 10.1158/1055-9965.EPI-08-0814]
97. Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, Ge YY, Yang JR, Su H, Zhuang SM. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 2008; 29: 2126-2131 [PMID: 18711148 DOI: 10.1093/carcin/bgn195]
98. Wang N, Tian ZQ, Li Y, Zhou RM, Wang GY. An A/G polymorphism rs3746444 in miR-499 is associated with increased cancer risk: a meta-analysis. Genet Mol Res 2013; 12: 3955-3964 [PMID: 24085457 DOI: 10.4238/2013.September.23.14]
99. Gazouli M, Papaconstantinou I, Stamatis K, Vaiopoulou A, Zeglinas C, Vassiliou I, Giokas G, Tzathas C. Association study of genetic variants in miRNAs in patients with inflammatory bowel disease: preliminary results. Dig Dis Sci 2013; 58: 2324-2328 [PMID: 23543085 DOI: 10.1007/s10620-013640-y]
100. De Iudicibus S, Stocco G, Martelossi S, Londero M, Ebner E, Pontillo A, Lionetti P, Barabino A, Bartoli F, Ventura A, Decorti G. Genetic predictors of glucocorticoid response in pediatric patients with inflammatory bowel diseases. J Clin Gastroenterol 2011; 45: e1-e7 [PMID: 20697295 DOI: 10.1097/ MCG.0b013e3181e8ae93]
101. Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, Yonemura J, Kamiya Y, Ishizuka T, Nakagawa Y, Nagasaka M, Iwata M, Yamada H, Hirata I, Arisawa T. Association study of common genetic variants in pre-microRNAs in patients with ulcerative colitis. J Clin Immunol 2011; 31: 69-73 [PMID: 20848167 DOI: 10.1007/s10875-010-9461-y]